a. For the most recent 12 month period available, the number of venesection procedures carried out by your organisation as a therapy or treatment for genetic haemochromatosis?
b. For the most recent 12 month period available, the average total cost of a venesection appointment (to include clinical consumables, nursing or phlebotomy staff time, administrative overheads etc.)
